Is Danaher Corporation (DHR) a Quality Compounder With Long-Term Revenue Growth?
Baron Funds released its “Baron Durable Advantage Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Danaher Corp (DHR)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Generation Investment Management David Blood And Al Gore | 4,965,646 | $980,913,714 | +57% | 6.24% |
| 2. | Fisher Asset Management Ken Fisher | 4,340,636 | $857,449,398 | -7% | 0.34% |
| 3. | Viking Global Andreas Halvorsen | 2,907,515 | $574,350,513 | +544% | 1.66% |
| 4. | Eagle Capital Management Boykin Curry | 2,859,518 | $564,869,280 | 1.86% | |
| 5. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 2,627,803 | $519,096,205 | +18% | 0.37% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $247.89 | 100 | $24,789.00 | 3,256 | 2022-05-16 | Filing | |
| $247.89 | 100 | $24,789.00 | 3,256 | 2022-05-16 | Filing | |
| $221.46 | 900 | $199,314.00 | 3,156 | 2021-02-26 | Filing | |
| $221.46 | 900 | $199,314.00 | 3,156 | 2021-02-26 | Filing | |
| $221.59 | 4,800 | $1,063,632.00 | 2,409,190 | 2021-02-26 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $211.06 | 2,778 | $586,319.12 | 20,751 | 2025-08-22 | Filing | |
| $200.83 | 47,316 | $9,502,472.28 | 3,105,808 | 2025-05-12 | Filing | |
| $199.67 | 158,951 | $31,737,746.17 | 3,153,124 | 2025-05-12 | Filing | |
| $199.15 | 164,412 | $32,742,649.80 | 3,312,075 | 2025-05-12 | Filing | |
| $197.86 | 58,313 | $11,537,810.18 | 3,476,487 | 2025-05-12 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 60,769,587 | $12,004,424,215 | 0.19% | |
| 2. | 52,233,943 | $10,318,293,235 | 0.2% | |
| 3. | 27,299,515 | $5,401,376,645 | 0.2% | |
| 4. | 17,076,280 | $3,373,248,350 | 0.61% | |
| 5. | 16,445,289 | $3,248,897,853 | 0.56% |
News See All
Wells Fargo Reduces PT on Danaher Corporation (DHR) to $205; Maintains ‘Equal Weight’ Rating
With a year-to-date decline in share price, along with strong hedge fund interest, Danaher Corporation (NYSE:DHR) secures a place on our list of the 11 Best Rebound Stocks to Buy According to Hedge Funds...
11 Best Rebound Stocks to Buy According to Hedge Funds
Following ongoing market uncertainty over tariffs and inflation, U.S. equities climbed to record highs on August 12, 2025, injecting a dose of optimism.
Is it a Great Time to Invest in Danaher Corp. (DHR)?
Parnassus Investments, an investment management firm that focuses on owning a concentrated portfolio of U.S.
Danaher Corporation (DHR): Maybe It Can Be Great Again, Says Jim Cramer
Danaher Corporation (NYSE:DHR) is a stock that Jim Cramer has a bittersweet relationship with. His trust has continued to hold the shares despite the fact that they have lost 11.7% year-to-date.
Jim Cramer Shed Light on These 15 Stocks
On Thursday, Mad Money host Jim Cramer pushed back against growing skepticism around Big Tech’s aggressive investment in artificial intelligence, especially by major cloud players often referred to ...
11 Stocks That Jim Cramer Recently Talked About
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer discussed why fighter and bomber pilots lead to high defense spending.
Danaher (DHR) Stock Upgraded on Biotech and Diagnostics Growth Outlook
Danaher Corporation (NYSE:DHR) ranks among the best non-tech stocks to buy according to billionaires.
Danaher Corporation (DHR)'s Been A Disaster, Says Jim Cramer
Danaher Corporation (NYSE:DHR) is an American life sciences, diagnostics, and biotechnology equipment provider. Its shares have lost 11% year-to-date, and Cramer isn’t a fan of the stock either.
UBS Lowers PT on Danaher Corporation (DHR) to $225 From $240, Keeps a Buy Rating
Danaher Corporation (NYSE:DHR) is one of the best strong buy healthcare stocks to buy now.